Zama, Japan

Ryuichi Horie



Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 95(Granted Patents)


Location History:

  • Kawasaki, JP (1996 - 1999)
  • Kanagawa, JP (2003 - 2004)
  • Kanagawa-ken, JP (2006)
  • Zama, JP (2001 - 2009)

Company Filing History:


Years Active: 1996-2009

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Ryuichi Horie: Innovator in Gene Detection Technologies

Introduction

Ryuichi Horie is a prominent inventor based in Zama, Japan. He has made significant contributions to the field of gene detection, holding a total of 9 patents. His work focuses on developing innovative reagents and methods for detecting specific genes related to various pathogens.

Latest Patents

Among his latest patents, Horie has developed a detection reagent for identifying thermostable direct hemolysin-related hemolysin (TRH) gene. This reagent specifically amplifies TRH1 and TRH2 RNA, utilizing a first primer that is complementary to a specific sequence of RNA derived from the TRH gene, and a second primer that is homologous to that specific sequence. Another notable invention is a combination of oligonucleotides designed for rapid and specific gene testing of the Shiga toxin family gene type 2 (stx) of entero-hemorrhagic E. coli (EHEC). This method allows for the detection of stx2 RNA by amplifying only stx2 RNA using a primer that is complementary to a base sequence specific for the stx2 gene.

Career Highlights

Horie has worked with notable companies such as Tosoh Corporation and Fujitsu Corporation. His experience in these organizations has contributed to his expertise in the field of biotechnology and gene detection.

Collaborations

Some of his coworkers include Noriyoshi Masuda and Kiyoshi Yasukawa, who have collaborated with him on various projects related to gene detection technologies.

Conclusion

Ryuichi Horie's innovative work in gene detection has made a significant impact in the field of biotechnology. His patents reflect his commitment to advancing methods for identifying critical genes, which can lead to improved diagnostics and treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…